Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Methods employed for induction and analysis of experimental myocardial infarction in mice.

Borst O, Ochmann C, Schönberger T, Jacoby C, Stellos K, Seizer P, Flögel U, Lang F, Gawaz M.

Cell Physiol Biochem. 2011;28(1):1-12. doi: 10.1159/000331708. Review.

2.

Usefulness of MRI to differentiate between temporary and long-term coronary artery occlusion in a minimally invasive model of experimental myocardial infarction.

Abegunewardene N, Vosseler M, Gori T, Hoffmann N, Schmidt KH, Becker D, Kreitner KF, Petersen SE, Schreiber LM, Horstick G, Münzel T.

Cardiovasc Intervent Radiol. 2009 Sep;32(5):1033-41. doi: 10.1007/s00270-009-9596-5.

PMID:
19472001
3.

Electrophysiological characterization of murine myocardial ischemia and infarction.

Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, Berul CI.

Basic Res Cardiol. 2001 May-Jun;96(3):237-50.

PMID:
11403417
4.

Strain-rate imaging predicts the attenuation of left ventricular remodeling induced by ischemic postconditioning after myocardial infarction in mice.

Thibault H, Gomez L, Bergerot C, Augeul L, Scherrer-Crosbie M, Ovize M, Derumeaux G.

Circ Cardiovasc Imaging. 2011 Sep;4(5):550-7. doi: 10.1161/CIRCIMAGING.110.962282.

5.

Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.

Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J.

Circulation. 2007 Apr 10;115(14):1866-75.

6.

Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.

Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP.

Circ Res. 2009 Mar 13;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746.

8.

Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.

Weinberg EO, Scherrer-Crosbie M, Picard MH, Nasseri BA, MacGillivray C, Gannon J, Lian Q, Bloch KD, Lee RT.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1802-9.

9.

RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.

Aleshin A, Ananthakrishnan R, Li Q, Rosario R, Lu Y, Qu W, Song F, Bakr S, Szabolcs M, D'Agati V, Liu R, Homma S, Schmidt AM, Yan SF, Ramasamy R.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1823-32. doi: 10.1152/ajpheart.01210.2007.

10.

Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.

Arslan F, Smeets MB, O'Neill LA, Keogh B, McGuirk P, Timmers L, Tersteeg C, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP.

Circulation. 2010 Jan 5;121(1):80-90. doi: 10.1161/CIRCULATIONAHA.109.880187.

11.

Myocardial infarction: animal models.

Chimenti S, Carlo E, Masson S, Bai A, Latini R.

Methods Mol Med. 2004;98:217-26.

PMID:
15064443
12.

Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.

Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, Lerch R, Deruaz M, Proudfoot AE, Mach F.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1371-7. doi: 10.1161/ATVBAHA.110.206011.

13.

Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.

Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA.

Circulation. 1998 Sep 8;98(10):1006-14.

14.

Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury.

Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH.

Ann Thorac Surg. 2007 Jul;84(1):120-5.

PMID:
17588397
15.

Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction.

Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC, Becker LC, Lima JA.

Circulation. 2000 Jun 13;101(23):2734-41.

16.

Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells.

Hendry SL 2nd, van der Bogt KE, Sheikh AY, Arai T, Dylla SJ, Drukker M, McConnell MV, Kutschka I, Hoyt G, Cao F, Weissman IL, Connolly AJ, Pelletier MP, Wu JC, Robbins RC, Yang PC.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):1028-1037.e1. doi: 10.1016/j.jtcvs.2007.12.053.

17.

Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice.

Jong WM, Reitsma PH, ten Cate H, de Winter RJ.

Comp Med. 2003 Oct;53(5):522-6.

PMID:
14655995
18.

Mouse strain determines the outcome of wound healing after myocardial infarction.

van den Borne SW, van de Schans VA, Strzelecka AE, Vervoort-Peters HT, Lijnen PM, Cleutjens JP, Smits JF, Daemen MJ, Janssen BJ, Blankesteijn WM.

Cardiovasc Res. 2009 Nov 1;84(2):273-82. doi: 10.1093/cvr/cvp207.

19.

The effect of G-CSF in a myocardial ischemia reperfusion model rat.

Ieishi K, Nomura M, Kawano T, Fujimoto S, Ikefuji H, Noda Y, Nishikado A, Ito S.

J Med Invest. 2007 Feb;54(1-2):177-83.

20.

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.

Romanic AM, Harrison SM, Bao W, Burns-Kurtis CL, Pickering S, Gu J, Grau E, Mao J, Sathe GM, Ohlstein EH, Yue TL.

Cardiovasc Res. 2002 Jun;54(3):549-58.

Items per page

Supplemental Content

Support Center